Mylan (Switzerland)

Mylan (Switzerland)

Mylan N.V. was a global generic and specialty pharmaceuticals company. In November 2020, Mylan merged with Upjohn, Pfizer's off-patent medicine division, to form Viatris. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Mylan (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

57%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

89K


Open Access
Percentage

57%


Total
Publications

2.1K


Total Open
Publications

1.2K


Total
Citations

89K

Wikipedia

Website

download

Breakdown

24% 18% 15% 43%

Publisher Open

24%

Both

18%

Other Platform Open

15%

Closed

43%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

020406080100120140160Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

29%OA Journal

OA Journal 29%

260

Hybrid 42%

380

No Guarantees 29%

257

Other Platform Open

Institution 69%

481

Domain 28%

192

Other Internet 18%

125

Public 13%

93

Preprint 6%

42

Other Platform Locations

Name

Platform Type

Publications

Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca
Institution
185
PubMed Central
Domain
185
Europe PMC
Domain
114
University of Castilla La Mancha - Virtual Community of Pathological Anatomy
Institution
111
Semantic Scholar
Public
78
University of Milano-Bicocca - BOA - Bicocca Open Archive
Institution
61
INFN Catania - INFM-OAR
Other Internet
37
arXiv
Preprint
22
University College London - UCL Discovery
Institution
20
Figshare
Public
20
1 / 18

Data updated 7 April 2025

Share

Share

Share